CD274 and cancer: There is evidence that exosomes harboring PD-L1 can replicate the effect of cell-surface PD-L1, it may be used as a therapeutic adjuvant by decreasing exosomal PD-L1 to increase the effectiveness of PD-1/PD-L1 therapy in cancer (81).